サイバーフィジカル分野におけるイノベーションのアイデアを思い付いた場合、次のステップはどうすればよいのでしょうか？誰もが何から取り組むのか理解していたり、成功する自信があるわけではありません。当社では、DVF(Desirability：必要性、Viability：持続可能性、Feasibility：実現可能性) で知られるデザイン思考の手法を採用し、製品開発を進めています。

弊社は量子センシング技術のリーダーであるスイスのQnami社から、バイオメディカル分野においてNV磁力計が臨床的価値を提供し、新たなビジネスを生み出す可能性のあるアプリケーションを特定するよう依頼されました。

The world of DNA testing is changing fast and the race is on to provide cheap, quick genetic diagnoses for patients. Symon Cotton, Head of Life Sciences takes a look at the opportunities on offer for companies working in this ...

Cell4D is developing ‘fingerprinting’ technology for live cells using mechanomics, a discipline sitting at the intersection of biology and biomechanics. This biomarker that is used to screen and sort live cells for cell therapies ...

グローバル製薬企業は成功と失敗の大きな分かれ道に差し掛かっています。このような状況下では、業界が一丸となって新技術のもたらす一世一代のチャンスを掴むことが欠かせません。

Founders of early-stage start-ups are passionate, driven and optimistic. So, as they embark on the mission to sell their vision, they should accentuate the positive and keep negative thoughts of risk to the back of their mind, right? Wrong ...

AI-based methods are offering superhuman image enhancement. But their medical applications are not without risk – unless, that is, you consider a hybrid approach ...

How do we ensure that not only the rich benefit from cell and gene therapy? Rob Collison of Cambridge Consultants says: It’s about more than cutting costs ...

This whitepaper describes the benefits of introducing advanced wireless capabilities into surgical and critical care settings, the technical approaches to achieve this, and the challenges that can arise. It concludes with our vision for some exemplar use cases.  ...